Prestige Consumer Healthcare (Prestige Consumer Healthcare) Total Revenue Growth Rate (Future 3Y To 5Y Est) : 1.82 (As of Apr. 27, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare Total Revenue Growth Rate (Future 3Y To 5Y Est)?

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Prestige Consumer Healthcare's Total Revenue Growth Rate (Future 3Y To 5Y Est) is 1.82.

Competitive Comparison of Prestige Consumer Healthcare's Total Revenue Growth Rate (Future 3Y To 5Y Est)

For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prestige Consumer Healthcare's Total Revenue Growth Rate (Future 3Y To 5Y Est) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:

* The bar in red indicates where Prestige Consumer Healthcare's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.

Prestige Consumer Healthcare (NYSE:PBH) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation

Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.

Prestige Consumer Healthcare Total Revenue Growth Rate (Future 3Y To 5Y Est) Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Consumer Healthcare (Prestige Consumer Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (NYSE:PBH) » Definitions » Total Revenue Growth Rate (Future 3Y To 5Y Est)

Comparable Companies

Traded in Other Exchanges

PBV:Germany

Address

660 White Plains Road, Tarrytown, NY, USA, 10591

Website

https://www.prestigebrands.com

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Executives

Mary Beth Fritz	officer: Senior VP Quality & Regulatory	660 WHITE PLAINS RD, 2ND FL, TARRYTOWN NY 10591
Ronald M. Lombardi	officer: Chief Executive Officer	660 WHITE PLAINS RD., TARRYTOWN NY 10591
James Darecca	director	C/O HAEMONETICS CORPORATION, 125 SUMMER STREET, BOSTON MA 02110
Christine Sacco	officer: Chief Financial Officer	C/O SMART BALANCE, INC., 115 WEST CENTURY ROAD, SUITE 260, PARAMUS NJ 07652
Adel Mekhail	other: EVP, Marketing & Sales	660 WHITE PLAINS RD., 2ND FL, TARRYTOWN NY 10591
William P'pool	officer: See Remarks	2400 WEST LLOYD EXPRESSWAY, EVANSVILLE IL 47721
Celeste A. Clark	director	C/O ADVANCEPIERRE FOODS HOLDINGS, INC., 9987 CARVER ROAD, BLUE ASH OH 45242
Christopher J Coughlin	director
Natale S Ricciardi	director	C/O MORRIS COMMUNICATIONS CORP, 725 BROAD ST., AUGUSTA GA 30903
James M Jenness	director	PO BOX 3599, BATTLECREEK MI 49016-3599
John E Byom	director	660 WHITE PLAINS RD., TARRYTOWN NY 10591
Sheila Hopkins	director	C/O WARNACO INC, 90 PARK AVENUE, NEW YORK NY 10016
Dawn M. Zier	director	600 OFFICE CENTER DRIVE, FORT WASHINGTON PA 19034
Jeffrey Zerillo	officer: Senior VP Operations	660 WHITE PLAINS RD, 2ND FL, TARRYTOWN NY 10591
Timothy Connors	officer: Chief Marketing Officer	660 WHITE PLAINS RD., SUITE 205, TARRYTOWN NY 10591